Definitive Contract 140D6318C0010
Award Date
3/7/18
Potential Completion Date
6/11/19
Potential Value
$221K
Funding Federal Agency
Defense Advanced Research Projects Agency
Contracting Federal Agency
Interior Business Center
Awardee
Scribe Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94117, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
131
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,492,018.00 Firm Fixed Price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Scribe Biosciences, Inc., a small business, under the SBIR Program Phase II. The contract is for the development of "NEW PLATFORM TECHNOLOGIES FOR VIRAL AND THERAPEUTIC EVOLUTION ASSAYS." This contract is set aside for small businesses. Scribe Biosciences has previously received awards from the National Institutes of Health, National Science Foundation, and...
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
This is a $149,661.75 firm-fixed-price Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer. The contract is for the development of a next-generation cell-free prototyping and biomanufacturing platform. Biodiscovery LLC, a subsidiary of the Japanese chemical company Daicel Corporation, specializes in custom molecular...
This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...
This is a $583,435.00 firm-fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Senti Biosciences, Inc. for a Biological Technologies Office study on programmable therapeutic cell circuit platforms. The contract has a completion date of January 31, 2018 and does not have a set-aside designation. As DARPA is the Defense Department's advanced research agency, this contract is likely part of their efforts to develop novel biotechnology capabilities for...
<p>This is a $149,998.88 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to De Novo DNA, a self-certified small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for "HIGHLY SCALABLE MULTIPLEXED CRISPR APPLICATIONS USING ADVANCED PART TOOLBOXES AND CIRCUITS" and has an ultimate completion date of October 7, 2018. The contract is designated as a Total Small Business set-aside.</p>
This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...
This is a Firm Fixed Price, Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) under the SBIR Program Phase II to De Novo DNA, a self-certified small disadvantaged business. The contract is for the development of "HIGHLY SCALABLE MULTIPLEXED CRISPR TECHNOLOGIES FOR MEDICAL, INDUSTRIAL, AND AGRICULTURAL" and has a ceiling value of $1,959,347.00. The contract was awarded on September 18, 2018 and is set to be completed by November 17, 2021. This contract...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad...
This is a $300,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics", which was one of the research topics identified in the...